These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 20698225

  • 1. JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.
    Qin J, Wang Z, Wang Y, Ma L, Ni Q, Ke J.
    Hepatogastroenterology; 2010; 57(99-100):547-53. PubMed ID: 20698225
    [Abstract] [Full Text] [Related]

  • 2. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma.
    Berg JP, Zhou Q, Breuhahn K, Schirmacher P, Patil MA, Chen X, Schäfer N, Höller TT, Fischer HP, Büttner R, Gütgemann I.
    Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785
    [Abstract] [Full Text] [Related]

  • 3. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer.
    Esteva FJ, Sahin AA, Rassidakis GZ, Yuan LX, Smith TL, Yang Y, Gilcrease MZ, Cristofanilli M, Nahta R, Pusztai L, Claret FX.
    Clin Cancer Res; 2003 Nov 15; 9(15):5652-9. PubMed ID: 14654548
    [Abstract] [Full Text] [Related]

  • 4. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M.
    Clin Cancer Res; 2001 Dec 15; 7(12):4130-5. PubMed ID: 11751512
    [Abstract] [Full Text] [Related]

  • 5. [Inhibitory effect of arsenic trioxide on proliferation of human hepatocellular carcinoma cell line SMMC-7721 and the mechanism].
    Cui XP, Wang Y, Lu MD, Li P, Shen AG.
    Ai Zheng; 2007 Dec 15; 26(12):1304-8. PubMed ID: 18076791
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.
    Shiraso S, Katayose Y, Yamamoto K, Mizuma M, Yabuuchi S, Oda A, Rikiyama T, Onogawa T, Yoshida H, Hayashi H, Ohtsuka H, Motoi F, Egawa S, Kato J, Unno M.
    Anticancer Res; 2009 Jun 15; 29(6):2015-24. PubMed ID: 19528460
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC.
    Clin Cancer Res; 2008 Jul 01; 14(13):4045-52. PubMed ID: 18593980
    [Abstract] [Full Text] [Related]

  • 8. Significance of Jab1 expression in human esophageal squamous cell carcinoma.
    Wang F, Wang Y, Yu X, Yang D, Wang Z, Lu C, Yuan Z, Xiao M, Shen A.
    J Clin Gastroenterol; 2009 Jul 01; 43(6):520-6. PubMed ID: 19349901
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1.
    Hsieh YH, Su IJ, Wang HC, Tsai JH, Huang YJ, Chang WW, Lai MD, Lei HY, Huang W.
    Mol Cancer Res; 2007 Oct 01; 5(10):1063-72. PubMed ID: 17951406
    [Abstract] [Full Text] [Related]

  • 10. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
    Claudio PP, Russo G, Kumar CA, Minimo C, Farina A, Tutton S, Nuzzo G, Giuliante F, Angeloni G, Maria V, Vecchio FM, Campli CD, Giordano A.
    Clin Cancer Res; 2004 May 15; 10(10):3509-17. PubMed ID: 15161709
    [Abstract] [Full Text] [Related]

  • 11. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).
    Kouvaraki MA, Rassidakis GZ, Tian L, Kumar R, Kittas C, Claret FX.
    Cancer Res; 2003 Jun 01; 63(11):2977-81. PubMed ID: 12782606
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of Jun activation domain-binding protein 1 in nonsmall cell lung cancer and its significance in p27 expression and clinical features.
    Osoegawa A, Yoshino I, Kometani T, Yamaguchi M, Kameyama T, Yohena T, Maehara Y.
    Cancer; 2006 Jul 01; 107(1):154-61. PubMed ID: 16721818
    [Abstract] [Full Text] [Related]

  • 13. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.
    Jeon JH, Lee KN, Hwang CY, Kwon KS, You KH, Choi I.
    Cancer Res; 2005 Jun 01; 65(11):4485-9. PubMed ID: 15930262
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
    Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, Ku Y, Okabayashi T, Hanazaki K, Hiroi M, Izumi S, Mano S, Okada S, Karasawa Y, Maeba T, Suzuki Y.
    Ann Surg Oncol; 2009 Feb 01; 16(2):395-403. PubMed ID: 19034576
    [Abstract] [Full Text] [Related]

  • 15. Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.
    Ahn J, Hong SA, Lee SE, Kim J, Oh YS, Park SJ, Chung YJ.
    Endocr J; 2009 Feb 01; 56(5):707-13. PubMed ID: 19461157
    [Abstract] [Full Text] [Related]

  • 16. [Overexpression of p27(KIP1) induced by Bak gene leads to the arrest in G(1) phase of HCC-9204 cell line].
    Li J, Wang W, Yu X, Yang X, Hou Y.
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jul 01; 9 Suppl():27-9. PubMed ID: 11509132
    [Abstract] [Full Text] [Related]

  • 17. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.
    Qin LF, Ng IO.
    Hum Pathol; 2001 Aug 01; 32(8):778-84. PubMed ID: 11521219
    [Abstract] [Full Text] [Related]

  • 18. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression.
    Ito Y, Yoshida H, Matsuzuka F, Matsuura N, Nakamura Y, Nakamine H, Kakudo K, Kuma K, Miyauchi A.
    Anticancer Res; 2003 Aug 01; 23(5b):4121-5. PubMed ID: 14666612
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M.
    Oncol Rep; 2006 Apr 01; 15(4):765-71. PubMed ID: 16525656
    [Abstract] [Full Text] [Related]

  • 20. Skp2 and Jab1 expression are associated with inverse expression of p27(KIP1) and poor prognosis in oral squamous cell carcinomas.
    Shintani S, Li C, Mihara M, Hino S, Nakashiro K, Hamakawa H.
    Oncology; 2003 Apr 01; 65(4):355-62. PubMed ID: 14707456
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.